Trials / Completed
CompletedNCT05830864
Multicenter Retrospective Study of Isoflurane in Refractory and Super-Refractory Status Epilepticus
Multicenter Retrospective Study of Isoflurane in Refractory and Super-Refractory Status Epilepticus (I-Seizure)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 66 (actual)
- Sponsor
- Hopital of Melun · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Isoflurane might be used as anticonvulsive therapy in refractory status epilepticus. The aim of the study is to assess the efficiency of Isoflurane in this indication.
Detailed description
Investigators will collect in 4 ICUs the data from consecutive patients hospitalized between january 2016 and january 2023. Included patient were those treated by Isoflurane for refractory status epilepticus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Isoflurane | no other intervention |
Timeline
- Start date
- 2024-06-30
- Primary completion
- 2025-09-22
- Completion
- 2025-09-22
- First posted
- 2023-04-26
- Last updated
- 2025-09-26
Locations
4 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05830864. Inclusion in this directory is not an endorsement.